Sustained Release Formulation of Somatropin (rDNA Origin)for Injection
NCT00600808
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Growth Hormone Deficiency
Interventions
DRUG:
BPLG-003
Sponsor
BioPartners GmbH
Collaborators
[object Object]